应用生物工程角膜治疗老视的前景展望  

Prospect for presbyopia correction using bioengineered cornea

作　　者：岑羽捷 冯云[1,2] 

机构地区：[1]北京大学第三医院,北京100191 [2]北京大学眼科中心,北京100191

出　　处：《转化医学电子杂志》2017年第8期6-8,共3页E-Journal of Translational Medicine

摘　　要：对老视的矫正和治疗正受到越来越多的关注,其矫正方式多样.以生物工程制备的脱细胞角膜基质作为较理想的角膜替代材料在临床上已开始应用.本文介绍生物工程角膜的特点及优势,并对其未来被应用于老视治疗的可能性加以分析.Presbyopia correction has been attracting increasing attention and it includes multiple approaches. The acellular corneal stroma,which was prepared on the basis of bioengineered cornea,has been recently begun to apply in the clinic as ideal corneal replacement material. This article introduces the properties and advantages of bioengineered cornea,and discusses the feasibilities of its being used in presbyopia treatments.

关 键 词：生物工程角膜 老视 脱细胞角膜基质 角膜层间植入术 

分 类 号：R772.2[医药卫生—眼科]